Skip to main content

2020 Roundup Risk Assessment To Be Dropped By EPA

2020 Roundup Risk Assessment To Be Dropped By EPA

2020 Roundup Risk Assessment To Be Dropped By EPA

Introduction

Federal environmental inspectors are dropping a contentious 2020 risk assessment on the link between Roundup and cancer, which featured the weedkiller's active key component, glyphosate.

The previous judgement by the United States Environmental Protection Agency (EPA) claimed that there was no proof that glyphosate caused cancer, which sparked an outcry in the scientific community and among consumer advocacy groups. As a result, the EPA was sued in March 2020, and the Ninth Circuit Court of Appeals ruled earlier this year that the agency had failed to follow its own criteria in producing the previous glyphosate assessment, ordering the agency to again review the risk by October 1.

The EPA informed the court last week that it will no longer pursue the lawsuit and is withdrawing the assessment because it cannot meet the court-imposed deadline, leaving glyphosate without a cancer risk assessment until it is reviewed again in 2026.

EPA officials emphasized that the agency's scientific conclusions have not changed, and that the removal of the assessment does not imply that regulators now think glyphosate causes cancer.

Glyphosate is the active component in Roundup and other weed killers that are extensively sold to consumers in the United States. The last EPA glyphosate safety evaluation was heavily criticized because it appeared to disregard warnings made by the World Health Organization's International Agency for Research on Cancer (IARC) in 2015, which opted to designate glyphosate as a likely carcinogen.

Following that warning, Bayer and its Monsanto subsidiary faced thousands of Roundup lawsuits filed by former Roundup users who developed non-lymphoma, Hodgkin's and internal documents were discovered that revealed the companies provided false and misleading information to consumers and regulators for years, implying glyphosate does not cause cancer.

Due to the complexities of the problems involved, the EPA now claims it will not be able to complete the evaluation until 2026. The agency has stated that it would not meet the October 1 court-ordered deadline, which left only 106 days to conduct the evaluation. Instead, the agency claims it will take four years to finish the review.

Depending on the severity of the findings, an EPA evaluation that finds glyphosate to be a cancer-causing chemical and a concern to the environment might result in additional limits or even Roundup recalls.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Teen E-cigarette Use Hits 10-Year Low

Categories: E-Cigarette: JUUL

Federal officials report a significant decline in teen vaping rates in the U.S., with about half a million fewer middle and high school…

Baltimore, Walgreens Reach Opioid Settlement Totaling $402.5m

Categories: Opioids

The City of Baltimore has reached a settlement with Walgreens over its involvement in the opioid crisis, marking the…

Drug Distributors Reach $300M Opioid Settlement

Categories: Opioids

The three largest U.S. drug distributors—McKesson Corp, Cencora Inc, and Cardinal Health Inc—have agreed to pay $300 million to settle claims by health insurers and benefit plans over their role in fueling the U.S.…

Labor Day Litigation Bonanza!     
Free Trials + 15% Discount!